Please assess the completion status of the following clinical trial:

Trial Title: Ice T Postoperative Multimodal Pain Regimen in FPMRS Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The inclusion criteria are the following:~* Consenting, English speaking women between ages 18 and 80 who will undergo same day vaginal female pelvic reconstructive surgery at MetroHealth Medical Center~* Ability to read VAS Scores~* Specific vaginal procedures include, but are not limited to:~  * Periurethral bulking~ * Perineoplasty~ * Complete vaginectomy~ * Le Forte colpocleisis~ * Anterior repair~ * Posterior repair~ * Enterocele repair~ * Anterior and posterior repair~ * Anterior, posterior and enterocele repair~ * Transvaginal mesh use~ * Sacrospinous ligament fixation~ * Uterosacral ligament suspension~ * Vaginal paravaginal defect repair~ * Midurethral Sling~ * Sphincteroplasty~ * Vaginal hysterectomy, for uterus 250 g or less~ * Vaginal hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s)~ * Vaginal hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s), with repair of enterocele~ * Vaginal hysterectomy, for uterus 250 g or less; with repair of enterocele~ * Vaginal hysterectomy, for uterus greater than 250 g~ * Vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s)~ * Vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s), with repair of enterocele~ * Vaginal hysterectomy, for uterus greater than 250 g; with repair of enterocele~Exclusion Criteria:~* The exclusion criteria are the following:~* History of chronic pelvic pain~* Abdominal surgery~* Laparoscopic surgery~* History of psychiatric disease~* Currently taking analgesic medications~* Currently taking sedatives~* Liver disease~* Renal disease with CrCl \< 60cc/min.~* History of burns from application of ice.~* Women who did not consent for the study.~* Intraoperative concern for increased blood loss~* Unable to speak English~* Unable to understand VAS Scores~* Undergoing concomitant abdominal or laparoscopic procedures.~* Allergy to motrin, toradol, Percocet, Tylenol~* Active or history of peptic ulcer disease~* History of GI bleeding or perforation~* Hemorrhagic diathesis~* Severe uncontrolled heart failure~* Inflammatory bowel disease

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- ICE T (Type: EXPERIMENTAL): 1. ICE PACKS applied to the perineum every hour for 20 minutes ATC until discharge.~2. 6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge.~3. Once out of the PACU will receive 1 gram of Tylenol every 6 hours for a total of 4 grams daily ATC until discharge~4. Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.~5. Patients will be discharged home with PO Tylenol and PO toradol PRN.
- Standard (Type: ACTIVE_COMPARATOR): 1. Motrin 600mg PO Q4h PRN pain 1-3~2. Percocet 1 tab PO Q4-6 hours PRN 4-6 pain~3. Percocet 2 tabs PO Q 7-10 hours PRN 7-10 pain~4. Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.~5. Patients will be discharged home with Motrin and Percocet for pain PRN.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete